Literature DB >> 20220308

RNA editing in kinetoplastids.

Stephen Hajduk1, Torsten Ochsenreiter.   

Abstract

RNA editing in kinetoplastid protozoa is a post-transcriptional process of uridine insertion or deletion in mitochondrial mRNAs. The process involves two RNA species, the pre-edited mRNA and in most cases a trans-acting guide RNA (gRNA). Sequences within gRNAs define the position and extend of mRNA editing. Both mRNAs and gRNAs are encoded by mitochondrial genes in the kinetoplast DNA (kDNA), which consists of thousands of small circular DNA molecules, called minicircles, encoding thousands of gRNAs, catenated together and with a few mRNA encoding larger circles, the maxicircles, to form a huge DNA network. Editing has been shown to result in translatable mRNAs of bona fide mitochondrial genes as well as novel alternatively edited transcripts that are involved in the maintenance of the kDNA itself. RNA editing occurs within large protein-RNA complexes, editosomes, containing gRNA, preedited and partially edited mRNAs and also structural and catalytically active proteins. Editosomes are diverse in both RNA and protein composition and undergoe structural remodeling during the maturation. The compositional and structural diversity of editosomes further underscores the complexity of the RNA editing process.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20220308     DOI: 10.4161/rna.7.2.11393

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  32 in total

1.  KREPB6, KREPB7, and KREPB8 are important for editing endonuclease function in Trypanosoma brucei.

Authors:  Xuemin Guo; Jason Carnes; Nancy Lewis Ernst; Matt Winkler; Kenneth Stuart
Journal:  RNA       Date:  2011-12-19       Impact factor: 4.942

2.  Trypanosoma brucei 20 S editosomes have one RNA substrate-binding site and execute RNA unwinding activity.

Authors:  Cordula Böhm; Venkata Subbaraju Katari; Michael Brecht; H Ulrich Göringer
Journal:  J Biol Chem       Date:  2012-06-01       Impact factor: 5.157

3.  Mutational analysis of Trypanosoma brucei editosome proteins KREPB4 and KREPB5 reveals domains critical for function.

Authors:  Jason Carnes; Achim Schnaufer; Suzanne M McDermott; Gonzalo Domingo; Rose Proff; Alodie G Steinberg; Irina Kurtz; Kenneth Stuart
Journal:  RNA       Date:  2012-08-23       Impact factor: 4.942

4.  Trypanosoma brucei Tb927.2.6100 is an essential protein associated with kinetoplast DNA.

Authors:  Kirsten Beck; Nathalie Acestor; Anjelique Schulfer; Atashi Anupama; Jason Carnes; Aswini K Panigrahi; Ken Stuart
Journal:  Eukaryot Cell       Date:  2013-05-06

5.  RNA catalyst as a reporter for screening drugs against RNA editing in trypanosomes.

Authors:  Houtan Moshiri; Vaibhav Mehta; Reza Salavati
Journal:  J Vis Exp       Date:  2014-07-22       Impact factor: 1.355

Review 6.  Manipulating and elucidating mitochondrial gene expression with engineered proteins.

Authors:  Christopher P Wallis; Louis H Scott; Aleksandra Filipovska; Oliver Rackham
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-12-02       Impact factor: 6.237

7.  Three mitochondrial DNA polymerases are essential for kinetoplast DNA replication and survival of bloodstream form Trypanosoma brucei.

Authors:  David F Bruhn; Mark P Sammartino; Michele M Klingbeil
Journal:  Eukaryot Cell       Date:  2011-04-29

Review 8.  Mitochondrial RNA processing in trypanosomes.

Authors:  Ruslan Aphasizhev; Inna Aphasizheva
Journal:  Res Microbiol       Date:  2011-05-01       Impact factor: 3.992

9.  Cancer in the parasitic protozoans Trypanosoma brucei and Toxoplasma gondii.

Authors:  Zhao-Rong Lun; De-Hua Lai; Yan-Zi Wen; Ling-Ling Zheng; Ji-Long Shen; Ting-Bo Yang; Wen-Liang Zhou; Liang-Hu Qu; Geoff Hide; Francisco J Ayala
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-20       Impact factor: 11.205

Review 10.  Inhibitors of RNA editing as potential chemotherapeutics against trypanosomatid pathogens.

Authors:  Reza Salavati; Houtan Moshiri; Smriti Kala; Hamed Shateri Najafabadi
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2011-11-13       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.